Vice President of Platform

About ScionxBio ScionxBio is engineering the next generation of RNA medicines, combining synthetic chemistry and artificial intelligence to create xRNA — a platform for long-acting therapeutics. By expanding RNA beyond nature's four-letter alphabet, we engineer molecules that sustain protein expression for weeks to months rather than days, with a lower immunogenic burden and the durability that chronic disease demands. At the heart of the platform is our TERA® engine, a closed-loop system in wh…